{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:24:25Z","timestamp":1755221065719,"version":"3.43.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1023\/a:1008821927289","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T11:51:56Z","timestamp":1040557916000},"page":"113-118","source":"Crossref","is-referenced-by-count":3,"title":["Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease"],"prefix":"10.1007","volume":"5","author":[{"given":"Hernan E.","family":"Grenett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van C.","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Nong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois M.","family":"Booyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"145361_CR1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.ATV.15.9.1444","volume":"15","author":"F Lupu","year":"1995","unstructured":"Lupu F, Heim D, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995;15:1444\u20131455.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"145361_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0268-9499(92)90086-W","volume":"6","author":"ES. Barnathan","year":"1992","unstructured":"Barnathan ES. Characterization and regulation of the urokinase receptor of human endothelial cells. Fibrinolysis 1992;6:1\u20139.","journal-title":"Fibrinolysis"},{"key":"145361_CR3","first-page":"662","volume-title":"The Molecular Basis of Blood Diseases","author":"D Collen","year":"1987","unstructured":"Collen D, Lijnen HR. Fibrinolysis and the control of hemostasis. In: Stamatovannopoulos G. Nienhuis AW, Leder P, Majerus P., eds. The Molecular Basis of Blood Diseases. Philadelphia: W.B. Saunders, 1987:662\u2013688."},{"key":"145361_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1642708","volume":"74","author":"HR Lijnen","year":"1995","unstructured":"Lijnen HR, Collen D. Fibrinolytic agents: Mechanisms of activity and pharmacology. Thromb Haemost 1995;74: 387\u2013390.","journal-title":"Thromb Haemost"},{"key":"145361_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-0038-1642648","volume":"74","author":"M. Verstraete","year":"1995","unstructured":"Verstraete M. The fibrinlytic system: From Petri dishes to genetic engineering. Thromb Haemost 1995;74:25\u201335.","journal-title":"Thromb Haemost"},{"key":"145361_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4684-3267-1_4","volume":"70","author":"FM Habal","year":"1976","unstructured":"Habal FM, Burrowes CE, Movat HZ. Generation of kinin by plasma kallikrein and plasmin and the effect of alpha 1-antitrypsin and antithrombin III on the kinongenases. Adv Exp Med Biol 1976;70:23\u201326.","journal-title":"Adv Exp Med Biol"},{"key":"145361_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0922-3371(90)90046-Y","volume":"32","author":"MS Pepper","year":"1991","unstructured":"Pepper MS, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differen Dev 1991;32:319\u2013328.","journal-title":"Cell Differen Dev"},{"key":"145361_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.122.3.673","volume":"122","author":"MS Pepper","year":"1993","unstructured":"Pepper MS, Sappino APS, R., Montesano R, Orci L, Vassali JD. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993;122:673\u2013684.","journal-title":"J Cell Biol"},{"key":"145361_CR9","first-page":"224","volume":"1","author":"G Murphy","year":"1992","unstructured":"Murphy G, Ward R, Gavilovic J, Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1992;1:224\u2013230.","journal-title":"Matrix Suppl"},{"key":"145361_CR10","first-page":"472","volume":"116","author":"J Jean-Claude","year":"1994","unstructured":"Jean-Claude J, Newman KM, Li H, Gregory AK, Tilson MD. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 1994;116:472\u2013478.","journal-title":"Surgery"},{"key":"145361_CR11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1515\/bchm3.1992.373.2.611","volume":"373","author":"M Schmitt","year":"1992","unstructured":"Schmitt M, Janicke F, Moniwa N, Chucholowski N, Pache L, Graeff H. Tumor-associated urokinase-type plasminogen activator: Biological and clinical significance [Review]. Biol Chem Hoppe-Seyler 1992;373:611\u2013622.","journal-title":"Biol Chem Hoppe-Seyler"},{"key":"145361_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.RES.75.3.539","volume":"75","author":"MP Bendeck","year":"1994","unstructured":"Bendeck MP, Zempo N, Clowes AW, et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75:539\u2013545.","journal-title":"Circ Res"},{"key":"145361_CR13","first-page":"377","volume-title":"Human Genes and Diseases","author":"F Blasi","year":"1986","unstructured":"Blasi F, Riccio A, Sebastio G. Human plasminogen activators: Genes and proteins structure. In: Blasi F, ed. Human Genes and Diseases. New York: John Wiley & Sons, 1986:377\u2013414."},{"key":"145361_CR14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0038-1653877","volume":"73","author":"OD Pedersen","year":"1995","unstructured":"Pedersen OD, Gram J, Jespersen J. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease. Thromb Haemost 1995; 73:835\u2013840.","journal-title":"Thromb Haemost"},{"key":"145361_CR15","doi-asserted-by":"crossref","first-page":"19686","DOI":"10.1073\/pnas.89.22.10686","volume":"89","author":"E Bacharach","year":"1992","unstructured":"Bacharach E, Itin A, Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 1992;89:19686\u2013109690.","journal-title":"Proc Natl Acad Sci USA"},{"key":"145361_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0344-0338(11)80726-0","volume":"191","author":"R Hildenbrand","year":"1995","unstructured":"Hildenbrand R, Dilger I, Horlin A, Stutte HJ. Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer. Pathol Res Pract 1995; 191:403\u2013409.","journal-title":"Pathol Res Pract"},{"key":"145361_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/aja.1001930105","volume":"193","author":"PG McGuire","year":"1992","unstructured":"McGuire PG, Orkin RW. Urokinase activity in the developing avian heart: A spatial and temporal analysis. Dev Dyn 1992;193:24\u201333.","journal-title":"Dev Dyn"},{"key":"145361_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.1992.tb51606.x","volume":"667","author":"CL Jackson","year":"1992","unstructured":"Jackson CL, Reidy MA. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann N Y Acad Sci 1992;667:141\u2013150.","journal-title":"Ann N Y Acad Sci"},{"key":"145361_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.ATV.15.1.37","volume":"15","author":"H Noda-Heiny","year":"1995","unstructured":"Noda-Heiny H, Daughtery A, Sobel BE. Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol 1995;15:37\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"145361_CR20","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1073\/pnas.84.23.8548","volume":"84","author":"KW Klinger","year":"1987","unstructured":"Klinger KW, Winqvist R, Riccio A, et al. Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci USA 1987;84:8548\u20138552.","journal-title":"Proc Natl Acad Sci USA"},{"key":"145361_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","volume":"11","author":"SJ Dawson","year":"1991","unstructured":"Dawson SJ, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991;11:183\u2013190.","journal-title":"Arterioscler Thromb"},{"key":"145361_CR22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","volume":"92","author":"P Eriksson","year":"1995","unstructured":"Eriksson P, Kallin B, van `T Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851\u20131855.","journal-title":"Proc Natl Acad Sci USA"},{"key":"145361_CR23","first-page":"251","volume":"2","author":"FJ Benham","year":"1984","unstructured":"Benham FJ, Spurr N, Povey S, et al. Assignment of tissuetype plasminogen activator to chromosome 8 in man and identification of a common restriction length polymorphism within the gene. Mol Biol Med 1984;2:251\u2013259.","journal-title":"Mol Biol Med"},{"key":"145361_CR24","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1093\/nar\/19.23.6661-a","volume":"19","author":"AD Borglum","year":"1991","unstructured":"Borglum AD, Byskov A, Cubellis MV, Kruse TA. An EcoRI polymorphism for the PLAUR gene. Nucleic Acids Res 1991;19:6661.","journal-title":"Nucleic Acids Res"},{"key":"145361_CR25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00219193","volume":"89","author":"AD Borglum","year":"1992","unstructured":"Borglum AD, Byskov A, Roldan AL, Kruse TA. Two PstI polymorphisms for the urokinase-type plasminogen activator receptor gene (PLAUR). Hum Genet 1992;89:584.","journal-title":"Hum Genet"},{"key":"145361_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0038-1653733","volume":"73","author":"H Iso","year":"1995","unstructured":"Iso H, Folsom AR, Winkelmann JC, et al. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995;73:106\u2013111.","journal-title":"Thromb Haemost"},{"key":"145361_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0049-3848(95)91608-N","volume":"77","author":"J Heinrich","year":"1995","unstructured":"Heinrich J, Funke H, Rust S, et al. Impact of polymorphisms in the alpha-and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995;77:209\u2013215.","journal-title":"Thromb Res"},{"key":"145361_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0038-1648177","volume":"65","author":"AE Thomas","year":"1991","unstructured":"Thomas AE, Green FR, Kelleher CH, et al. Variation in the promoter region of the b fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991;65:487\u2013490.","journal-title":"Thromb Haemost"},{"key":"145361_CR29","first-page":"154","volume":"44","author":"Q Yu","year":"1996","unstructured":"Yu Q, Safavi F, Robert R, Marian AJ. A variant of b fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction. J Investig Med 1996;44:154\u2013159.","journal-title":"J Investig Med"},{"key":"145361_CR30","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/blood.V75.10.1991.1991","volume":"75","author":"VW van Hinsbergh","year":"1990","unstructured":"van Hinsbergh VW, van den Berg EA, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990;75:1991\u20131998.","journal-title":"Blood"},{"key":"145361_CR31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.V79.3.678.678","volume":"79","author":"MJ Niedbala","year":"1992","unstructured":"Niedbala MJ, Picarella MS. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen. Blood 1992;79:678\u2013687.","journal-title":"Blood"},{"key":"145361_CR32","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood.V81.10.2608.2608","volume":"81","author":"MJ Niedbala","year":"1993","unstructured":"Niedbala MJ, Stein-Picarella M. Role or protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 1993;81:2608\u20132617.","journal-title":"Blood"},{"key":"145361_CR33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","volume":"258","author":"WB Kannel","year":"1987","unstructured":"Kannel WB, Wolf PA, Castelli WP, D'Agnostino RB. Fibrinogen and risk of cardiovascular disease. JAMA 1987;258:1183\u20131186.","journal-title":"JAMA"},{"key":"145361_CR34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0002-8703(87)90588-6","volume":"114","author":"WB. Kannel","year":"1987","unstructured":"Kannel WB. Hypertension and other risk facors in coronary heart disease. Am Heart J 1987;114:918\u2013925.","journal-title":"Am Heart J"},{"key":"145361_CR35","first-page":"269","volume-title":"Molecular Cloning: A Laboratory Manual","author":"T Maniatis","year":"1982","unstructured":"Maniatis T, Fritsch EF, Sambrook J. Construction of genomic libraries. In: Irwin N, Ford N, Nolan C, Ferguson M, Ockler M, eds. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982:269\u2013307.","edition":"2nd ed."},{"key":"145361_CR36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-230X(08)60028-7","volume":"44","author":"K Dano","year":"1985","unstructured":"Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985;44:139\u2013266.","journal-title":"Adv Cancer Res"},{"key":"145361_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0092-8674(86)90613-6","volume":"47","author":"P Mignatti","year":"1986","unstructured":"Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986;47:487\u2013498.","journal-title":"Cell"},{"key":"145361_CR38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0092-8674(83)90093-4","volume":"35","author":"L Ossowski","year":"1983","unstructured":"Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983;35:611\u2013619.","journal-title":"Cell"},{"key":"145361_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/aja.1001940304","volume":"194","author":"PG McGuire","year":"1992","unstructured":"McGuire PG, Alexander SM. Urokianse expression during the epithelial-mesenchymal transformation of the avian somite. Dev Dyn 1992;194:193\u2013197.","journal-title":"Dev Dyn"},{"key":"145361_CR40","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1083\/jcb.105.6.2535","volume":"105","author":"MS Pepper","year":"1987","unstructured":"Pepper MS, Vassalli JD, Montessano R, Orci L. Urokinasetype plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987;105:2535\u20132541.","journal-title":"J Cell Biol"},{"key":"145361_CR41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0022-2828(05)82394-6","volume":"27","author":"PS Knoepfler","year":"1995","unstructured":"Knoepfler PS, Bloor CM, Carroll SM. Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion. J Mol Cell Cardiol 1995;27:1317\u20131324.","journal-title":"J Mol Cell Cardiol"},{"key":"145361_CR42","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.ATV.15.9.1432","volume":"15","author":"PN Raghunath","year":"1995","unstructured":"Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1432\u20131443.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"145361_CR43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.RES.67.1.61","volume":"67","author":"AW Clowes","year":"1990","unstructured":"Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990;67:61\u201367.","journal-title":"Circ Res"},{"key":"145361_CR44","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.13.8.1218","volume":"13","author":"CL Jackson","year":"1993","unstructured":"Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993;13:1218\u20131226.","journal-title":"Arterioscler Thromb"},{"key":"145361_CR45","doi-asserted-by":"crossref","first-page":"13521","DOI":"10.1016\/S0021-9258(18)77378-X","volume":"265","author":"HG Welgus","year":"1990","unstructured":"Welgus HG, Fliszar CJ, Seltzer JL, Schmid TM, Jeffrey JJ. Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-k-Da type IV collagenase. J Biol Chem 1990;265:13521\u201313527.","journal-title":"J Biol Chem"},{"key":"145361_CR46","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1016\/S0021-9258(17)39034-8","volume":"260","author":"JR Chin","year":"1985","unstructured":"Chin JR, Murphy G, Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase: Biosynthesis, isolation, characterization, and substrates. J Biol Chem 1985;260:12367\u201312376.","journal-title":"J Biol Chem"},{"key":"145361_CR47","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1073\/pnas.88.18.8154","volume":"88","author":"AM Henney","year":"1991","unstructured":"Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991;88: 8154\u20138158.","journal-title":"Proc Natl Acad Sci USA"},{"key":"145361_CR48","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","volume":"94","author":"ZS Galis","year":"1994","unstructured":"Galis ZS, Sukhova G, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493\u20132503.","journal-title":"J Clin Invest"},{"key":"145361_CR49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1083\/jcb.109.1.309","volume":"109","author":"Y Sato","year":"1989","unstructured":"Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta1-like molecule by plasmin during co-culture. J Cell Biol 1989;109:309\u2013315.","journal-title":"J Cell Biol"},{"key":"145361_CR50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1083\/jcb.110.3.767","volume":"110","author":"O Saksela","year":"1990","unstructured":"Saksela O, Rifkin DB. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-medicated proteolytic activity. J Cell Biol 1990;110:767\u2013775.","journal-title":"J Cell Biol"},{"key":"145361_CR51","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1083\/jcb.110.4.1361","volume":"110","author":"RM Lyons","year":"1990","unstructured":"Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanisms of activation of latent recombinant transforming growth factor \u03b21 by plasmin. J Cell Biol 1990;110:1361\u20131367.","journal-title":"J Cell Biol"},{"key":"145361_CR52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0049-3848(94)90009-4","volume":"74","author":"C Yamamoto","year":"1994","unstructured":"Yamamoto C, Kaji T, Sakamoto M, Kozuka H, Koizumi F. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb Res 1994;74:163\u2013168.","journal-title":"Thromb Res"},{"key":"145361_CR53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.93.3.440","volume":"93","author":"I Behague","year":"1996","unstructured":"Behague I, Poirier O, Nicaud V, et al. \u03b2 fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. Circulation 1996;93:440\u2013449.","journal-title":"Circulation"},{"key":"145361_CR54","first-page":"179","volume":"42","author":"MJ. Niedbala","year":"1993","unstructured":"Niedbala MJ. Cytokine regulation of endothelial cell extracellular proteolysis (review). Agents Actions Suppl 1993;42: 179\u2013193.","journal-title":"Agents Actions Suppl"},{"key":"145361_CR55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0735-1097(87)80373-X","volume":"9","author":"J Mehta","year":"1987","unstructured":"Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987;9:263\u2013268.","journal-title":"J Am Coll Cardiol"},{"key":"145361_CR56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00405009","volume":"34","author":"A Fontbonne","year":"1991","unstructured":"Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356\u2013361.","journal-title":"Diabetologia"},{"key":"145361_CR57","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/01.ATV.14.12.1946","volume":"14","author":"B Eliasson","year":"1994","unstructured":"Eliasson B, Attvall S, Taskinen M, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994;14:1946\u20131950.","journal-title":"Arterioscler Thromb"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008821927289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1008821927289\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008821927289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:19:35Z","timestamp":1754637575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1008821927289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["145361"],"URL":"https:\/\/doi.org\/10.1023\/a:1008821927289","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}